Salicylate poisoning: An evidence-based consensus guideline for out-of-hospital management

Clinical Toxicology

Volumn 45, Issue 2, 2007, Pages 95-131

  Chyka, Peter A ^a   Erdman, Andrew R ^a   Christianson, Gwenn ^a   Wax, Paul M ^a   Booze, Lisa L ^a   Manoguerra, Anthony S ^a   Caravati, E Martin ^a   Nelson, Lewis S ^a   Olson, Kent R ^a   Cobaugh, Daniel J ^a   Scharman, Elizabeth J ^a   Woolf, Alan D ^a   Troutman, William G ^a  

^a American Association of Poison Control Centers   (United States)

Author keywords

Aspirin poisoning; Poison control centers standards; Practice guidelines; Salicylic acid poisoning

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED CARBON; BISMUTH SALICYLATE; CAFFEINE; CHLORDIAZEPOXIDE; CHOLINE MAGNESIUM TRISALICYLATE; CHOLINE SALICYLATE; CODEINE; IPECAC; MAGNESIUM CITRATE; MAGNESIUM SALICYLATE; PARACETAMOL; PHENAZONE; PROMETHAZINE; SALICYLATE SODIUM; SALICYLIC ACID; SALICYLIC ACID METHYL ESTER; SALSALATE; SORBITOL; TRIETHANOLAMINE SALICYLATE;

ABDOMINAL PAIN; ACNE; ADD ON THERAPY; AGITATION; BLEEDING; BLOOD CLOTTING DISORDER; BRAIN EDEMA; CARBOHYDRATE METABOLISM; CENTRAL NERVOUS SYSTEM DEPRESSION; CHRONIC TOXICITY; CLINICAL TRIAL; COMA; CONFERENCE PAPER; CONFUSION; CONSENSUS; DEATH; DEHYDRATION; DIAPHORESIS; DIARRHEA; DIGESTIVE SYSTEM ULCER; DISORDERS OF ACID BASE BALANCE; DIZZINESS; DRUG EXPOSURE; DRUG OVERDOSE; DYSPNEA; ELECTROLYTE DISTURBANCE; EMERGENCY CARE; EMERGENCY WARD; ERYTHEMA; EYE DISCOMFORT; GASTROINTESTINAL IRRITATION; HALLUCINATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEARING IMPAIRMENT; HEMATEMESIS; HEPATITIS; HUMAN; HYPERPNEA; HYPERPYREXIA; INTERNATIONAL NORMALIZED RATIO; INTOXICATION; LETHARGY; LIPID METABOLISM; LUNG EDEMA; METABOLIC ACIDOSIS; MOUTH PAIN; NAUSEA; NAUSEA AND VOMITING; NECROSIS; PATIENT CARE; PRACTICE GUIDELINE; PREGNANCY; PROTHROMBIN TIME; PSORIASIS; RECOMMENDED DRUG DOSE; RESPIRATORY DISTRESS; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SLURRED SPEECH; SORE THROAT; SYMPTOMATOLOGY; TACHYPNEA; THIRD TRIMESTER PREGNANCY; TINNITUS; VOMITING;

EVIDENCE-BASED MEDICINE; HUMANS; POISON CONTROL CENTERS; POISONING; SALICYLATES; TRIAGE;

EID: 33847238794     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650600907140     Document Type: Conference Paper

References (213)

1. Watson WA, Litovitz TL, Rodgers Jr GC, Klein-Schwartz W, Reid N, Youniss J, Flanagan A, Wruk KM. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589-666.
2. Vandenberg SA, Smolinske SC, Spoerke DG, Rumack BH. Non-aspirin salicylates: conversion factors for estimating aspirin equivalency. Vet Hum Toxicol 1989; 31:49-50.
3. Dromgoole SH, Cassell S, Furst DE, Paulus HE. Availability of salicylate from salsalate and aspirin. Clin Pharmacol Ther 1983; 34:539-545.
4. Chan TY. Salicylamide toxicity in overdose. Int J Clin Pharmacol Ther 1996; 34:366.
5. Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 1985; 10:164-177.
6. Elko C, Von Derau K. Salicylate undetected for 8 hours after enteric-coated aspirin overdose [abstract]. J Toxicol Clin Toxicol 2001; 39: 482-483.
7. Salhanick S, Levy D, Burns M. Aspirin bezoar proven by upper endoscopy [abstract]. J Toxicol Clin Toxicol 2002; 40:688.
8. Wolowich WR, Hadley CM, Kelley MT, Walson PD, Casavant MJ. Plasma salicylate from methyl salicylate cream compared to oil of wintergreen. J Toxicol Clin Toxicol 2003; 41:355-358.
9. Levy G. Pharmacokinetics of salicylate elimination in man. J Pharmaceut Sci 1965; 54:959-967.
10. Roberts II LJ, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill, 2001. p. 696-703.
11. Donovan JW, Akhtar J. Salicylates. In: Ford MD, Delaney KA. Ling J, Erickson T. Clinical Toxicology. Philadelphia: WB Saunders, 2001. p. 275-280.
12. Flomenbaum NE. Salicylates. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York: McGraw-Hill, 2002. p. 507-527.
13. Krenzelok EP, Kerr F, Proudfoot AT. Salicylate toxicity. In: Haddad LM, Shannon MW, Winchester JF, eds. Clinical Management of Poisoning and Drug Overdose. 3rd ed. Philadelphia: WB Saunders, 1998. p. 675-687.
14. Yip L. Salicylates. In: Dart RC, ed. Medical Toxicology. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins, 2004. p. 739-749.
15. Grant WM, Shuman JS. Toxicology of the Eye. 4th ed. Springfield: Charles C Thomas, 1993. p. 1250-1251.
16. Anderson RJ, Potts DE, Gabow PA, Rumack BH, Schrier RW. Unrecognized adult salicylate poisoning. Ann Intern Med 1976; 85:745-748.
17. Bailey RB, Jones SR. Chronic salicylate intoxication. A common cause of morbidity in the elderly. J Am Geriatr Soc 1989; 37:556-561.
18. Gaudreault P, Temple AR, Lovejoy FH, Jr. The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison. Pediatrics 1982; 70:566-569.
19. Temple AR. Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med 1981; 141:364-369.
20. Gabow PA, Anderson RJ, Potts DE, Schrier RW. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med 1978; 138:1481-1484.
21. Salicylic acid Drugdex evaluation:. In: Klasco RK, ed. Drugdex System. Thomson Micromedex, Greenwood Village (CO), edition expires March 2006.
22. Schwarb FP, Gabard B, Rufli T, Surber C. Percutaneous absorption of salicylic acid in man after topical administration of three different formulations. Dermatol 1999; 198:44-51.
23. Sacchetti A, Ramoska E. Ingestion of compound W, an unusual caustic. Am J Emerg Med 1986; 4:554-555.
24. Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a risk factor in Reye's syndrome. JAMA 1982; 247:3089-3094.
25. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281:1900-1905.
26. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139:493-498.
27. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC growth charts: United States. Advance data from vital and health statistics; no. 314. Hyattsville (MD): National Center for Health Statistics. 2000. Available at http://www.cdc.gov/nchs/data/ ad/ad314.pdf (accessed 28 March, 2005).
28. Done AK. Aspirin overdosage: incidence, diagnosis, and management. Pediatrics 1978; 62:890-897.
29. Salicylates management. In: Klasco RK, ed. Poisindex System. Greenwood Village (CO): Thomson Micromedex, edition expires March 2004.
30. Riley Jr HD, Worley L. Salicylate intoxication. Pediatrics 1956; 18:578-594.
31. Winters RW, White JS, Hughes MC, Ordway NK. Disturbances of acid-base equilibrium in salicylate intoxication. Pediatrics 1959; 23:260-285.
32. Cantrell FL, Nordt SP, Farson-Collier M. Low-dose aspirin poisoning in a child - how accurate are existing triage guidelines? [abstract]. Clin Toxicol (Phila) 2005; 43:647-648.
33. Leikin SL, Emmanouilides GC. The use of exchange transfusion in salicylate intoxication; report of 7 cases. J Pediatr 1960; 57:715-720.
34. Quak SH. Acid-base disturbance in salicylate intoxication - a local experience. J Singapore Paediatr Soc 1980; 22:50-55.
35. Ralston ME, Pearigen PD, Ponaman ML, Erickson LC. Transient myocardial dysfunction in a child with salicylate toxicity. J Emerg Med 1995; 13:657-659.
36. Schlegel RJ, Altstatt LB, Canales L, Goiser JL, Alexander JL, Gardner LI. Peritoneal dialysis for severe salicylism: an evaluation of indications and results. J Pediatr 1966; 69:553-562.
37. Schwartz R, Fellers FX, Knapp J, Yaffe S. The renal response to administration of acetazolamide (Diamox) during salicylate intoxication. Pediatrics 1959; 23:1103-1114.
38. Todd PJ, Sills JA, Harris F, Cowen JM. Problems with overdoses of sustained release aspirin. Lancet 1981; 1:777.
39. Williams SW. Treatment of aspirin poisoning by intravenous sodium lactate solution. Br Med J 1937; 1:550-552.
40. Fisher Jr CJ, Albertson TE, Foulke GE. Salicylate-induced pulmonary edema: clinical characteristics in children. Am J Emerg Med 1985; 3:33-37.
41. Adams JT, Bigler JA, Green OC. A case of methylsalicylate intoxication treated by exchange transfusion. J Am Med Asoc 1957; 165:1563-1565.
42. Cann HM, Verhulst HL. The salicylate problem with special reference to methyl salicylate. J Pediatr 1958; 53:271-276.
43. Diamond EF, DeYoung VR. Acute poisoning with oil of wintergreen treated by exchange transfusion. AMA J Dis Child 1958; 95:309-310.
44. Done AK. Exchange transfusion in the treatment of oil of wintergreen (methyl salicylate) poisoning. Pediatrics 1956; 18:80-85.
45. Howrie DL, Moriarty R, Breit R. Candy flavoring as a source of salicylate poisoning. Pediatrics 1985; 75:869-871.
46. Lester H, Davis K. Oil of wintergreen. Vet Hum Toxicol 1984; 26:308.
47. Levy G, Yaffe SJ. Relationship between dose and apparent volume of distribution in children. Pediatrics 1974; 54:713-717.
48. Malik AS, Zabidi MH, Noor AR. Acute salicylism due to accidental ingestion of a traditional medicine. Singapore Med J 1994; 35:215-216.
49. Rentsch JB, Bradley A, Marsh SB. Two cases of salicylate intoxication successfully treated by exchange transfusion. Am J Dis Child 1959; 98:778-785.
50. Stevenson CS. Oil of wintergreen (methyl salicylate) poisoning. Report of three cases, one with autopsy, and a review of the literature. Am J Med Sci 1937; 193:772-788.
51. Troll MM, Menten ML. Salicylate poisoning. Report of four cases. Am J Dis Child 1945; 69:37-43.
52. Vertrees JE, McWilliams BC, Kelly HW. Repeated oral administration of activated charcoal for treating aspirin overdose in young children. Pediatrics 1990; 85:594-598.
53. Oliver Jr TK, Dyer ME. The prompt treatment of salicylism with sodium bicarbonate. Am J Dis Child 1960; 99:553-565.
54. Beveridge GW, Forshall W, Munro JF, Weston IAG. Acute salicylate poisoning in adults. Lancet 1964; 41:1406-1408.
55. Dukes DC, Blainey JD, Cumming G, Widdowson G. The treatment of severe aspirin poisoning. Lancet 1963; 13:329-331.
56. Alvan G, Bergman U, Gustafsson LL. High unbound fraction of salicylate in plasma during intoxication. Br J Clin Pharmacol 1981; 11:625-626.
57. Berg KJ. Acute acetylsalicylic acid poisoning: treatment with forced alkaline diuresis and diuretics. Eur J Clin Pharmacol 1977; 12:111-116.
58. Biddle E. Aspirin poisoning. Br Med J 1938; 1:1365.
59. Black RA, Bensinger RE. Bilateral subconjunctival hemorrhage after acetylsalicylic acid overdose. Ann Ophthalmol 1982; 14:1024-1025.
60. Chase P, Walter F, James S. Whole bowel irrigation, hemodialysis, and continuous venovenous hemodiafiltration in the successful treatment of severe salicylate poisoning: Case report. Dial Transplant 2002; 31:387-391.
61. Dyke SC. A case of acetylsalicylic acid (aspirin) poisoning. Lancet 1935; 2:613-614.
62. Earle RJ. Congenital salicylate intoxication - report of a case. N Engl J Med 1961; 265:1003-1004.
63. Elliott GB, Crichton JU. Peritoneal dialysis in salicylate intoxication. Lancet 1960; 2:840-842.
64. Etchart LW. Peritoneal dialysis in salicylate intoxication. Rocky Mt Med J 1965; 62:55-56.
65. Fox GN. Hypocalcemia complicating bicarbonate therapy for salicylate poisoning. West J Med 1984; 141:108-109.
66. Ghose RR, Joekes AM. Treatment of severe aspirin poisoning without dialysis. Lancet 1964; 41:1409-1412.
67. Gren J, Woolf A. Hypermagnesemia associated with catharsis in a salicylate-intoxicated patient with anorexia nervosa. Ann Emerg Med 1989; 18:200-203.
68. Hantsch C, Seger D, Meredith T, McKinzie J, Santen S. Intra-alveolar hemorrhage in fatal salicylate toxicity [abstract]. J Toxicol Clin Toxicol 1998; 36:445-446.
69. Henry AF. Overdoses of Entrophen. Can Med Assoc J 1983; 128:1142.
70. Higgins RM, Connolly JO, Hendry BM. Alkalinization and hemodialysis in severe salicylate poisoning: comparison of elimination techniques in the same patient. Clin Nephrol 1998; 50:178-183.
71. Hopkins P. Aspirin poisoning, report of a case. Lancet. 1945; 1:145.
72. Hormaechea E, Carlson RW, Rogove H, Uphold J, Henning RJ, Weil MH. Hypovolemia, pulmonary edema and protein changes in severe salicylate poisoning. Am J Med 1979; 66:1046-1050.
73. Jackson AV. Toxic effects of salicylate on the foetus and mother. J Path Bact 1948; 60:587-592.
74. James SH, Martinak JF. Recovery following massive self-poisoning with aspirin. NY State J Med 1975; 75:1512-1514.
75. Krause DS, Wolf BA, Shaw LM. Acute aspirin overdose: mechanisms of toxicity. Ther Drug Monit 1992; 14:441-451.
76. Kwong TC, Laczin J, Baum J. Self-poisoning with enteric-coated aspirin. Am J Clin Pathol 1983; 80:888-890.
77. Leventhal LJ, Kuritsky L, Ginsburg R, Bomalaski JS. Salicylate-induced rhabdomyolysis. Am J Emerg Med 1989; 7:409-410.
78. Lewis FW. A case of aspirin poisoning. Lancet 1919.
79. Lipman BL, Krasnoff SO, Schless RA. Acute acetylsalicylic acid intoxication. Report of five cases with two deaths. Am J Dis Child 1949; 77:477-481.
80. Mofenson HC, Caraccio TR, Greensher J, D'Agostino R, Rossi A. Gastrointestinal dialysis with activated charcoal and cathartic in the treatment of adolescent intoxications. Clin Pediatr (Phila) 1985; 24:678-684.
81. Morgan AG, Polak A. Acetazolamide and sodium bicarbonate in treatment of salicylate poisoning in adults. Br Med J 1969; 1:16-19.
82. Neale AV. Aspirin poisining. Br Med J 1936; 1:109-110.
83. Pierce RP, Gazewood J, Blake Jr RL, Salicylate poisoning from enteric-coated aspirin. Delayed absorption may complicate management. Postgrad Med 1991; 89:61-62, 64.
84. Reid IR. Transient hypercalcemia following overdoses of soluble aspirin tablets. Aust N Z J Med 1985; 15:364.
85. Rejent TA, Baik S. Fatal in utero salicylism. J Forensic Sci 1985; 30:942-944.
86. Rivera W, Kleinschmidt KC, Velez LI, Shepherd G, Keyes DC. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother 2004; 38:1186-1188.
87. Robin ED, Davis RP, Rees SB. Salicylate intoxication with special reference to the development of hypokalemia. Am J Med 1959; 26:869-882.
88. Rupp DJ, Seaton RD, Wiegmann TB. Acute polyuric renal failure after aspirin intoxication. Arch Intern Med 1983; 143:1237-1238.
89. Savege TM, Ward JD, Simpson BR, Cohen RD. Treatment of severe salicylate poisoning by forced alkaline diuresis. Br Med J 1969; 1:35-36.
90. Schreiner GE, Berman LB, Griffin J, Feys J. Specific therapy for salicylism. N Engl J Med 1955; 253:213-217.
91. Surapathana LO, Futrakul P, Campbell RA. Salicylism revisited. Unusual problems in diagnosis and management. Clin Pediatr (Phila) 1970; 9:658-661.
92. Velez LI, Keyes DC, Roth B, Reynolds L, Purcell C. Aspirin overdose in mother and fetus [abstract]. J Toxicol Clin Toxicol 2001; 39:483-484.
93. Watson JE, Tagupa ET. Suicide attempt by means of aspirin enema. Ann Pharmacother 1994; 28:467-469.
94. Yambo CM, McFee RB, Caraccio TR, McGuigan MA. The ethical implications of delayed treatment for intentional aspirin overdose - a case report [abstract]. J Toxicol Clin Toxicol 2002; 40:690-691.
95. Cohen A. Comparison of two oral dosage forms of choline magnesium trisalicylate: bioavailability/bioequivalence study. Curr Ther Res Clin Exp 1980; 27:692-698.
96. Chan TY. Ingestion of medicated oils by adults: the risk of severe salicylate poisoning is related to the packaging of these products. Hum Exp Toxicol 2002; 21:171-174.
97. Baxter AJ, Mrvos R, Krenzelok EP. Salicylism and herbal medicine. Am J Emerg Med 2003; 21:448-449.
98. Cauthen WL, Hester WH. Accidental ingestion of oil of wintergreen. J Fam Pract 1989; 29:680-681.
99. Chan TH, Wong KC, Chan JC. Severe salicylate poisoning associated with the intake of Chinese medicinal oil (Red Flower Oil). Aust N Z J Med 1995; 25:57.
100. Hofman M, Diaz JE, Martella C. Oil of wintergreen overdose. Ann Emerg Med 1998; 31:793-794.
101. Tenney SM, Miller RM. The respiratory and circulatory actions of salicylate. Am J Med 1955; 19:498-508.
102. McGuigan MA. Death due to salicylate poisoning in Ontario. Can Med Assoc J 1986; 135:891-894.
103. Skjoto J, Reikvam A. Hyperthermia and rhabdomyolysis in self-poisoning with paracetamol and salicylates. Report of a case. Acta Med Scand 1979; 205:473-476.
104. Whitten CF, Kesaree NM, Goodwin JF. Managing salicylate poisoning in children. An evaluation of sodium bicarbonate therapy. Am J Dis Child 1961; 101:178-194.
105. Connell JR. Babies, dehydration, and aspirin. Rocky Mt Med J 1969; 66:57-61.
106. Craig JO, Ferguson IC, Syme J. Infants, toddlers, and aspirin. Br Med J 1966; 5490:757-761.
107. Ashworth CT, McKemie JF. Hemorrhagic complications with death from salicylate therapy. report of two cases. J Am Med Assoc 1944; 126:806-809.
108. Barnett HL, Powers JR, Benward JH, Martmann AF. Salicylate intoxication in infants and children. J Pediatr 1942; 20:214-223.
109. Bickers RG, Roberts RJ. Combined aspirin/acetaminophen intoxication. J Pediatr 1979; 94:1001-1003.
110. Brown DC, Savage JM. Therapeutic aspirin overdose in a three-year-old boy. Ulster Med J 1987; 56:63-65.
111. Bulugahapitiya DTD, Hebron B, Beck PR. Salicylate hepatitis with acidosis in an infant. Lancet 1979; 1:1295-1296.
112. Cotton EK, Fahlberg VI. Hypoglycemia with salicylate poisoning. A report of two cases. Am J Dis Child 1964; 108:171-173.
113. Dove DJ, Jones T. Delayed coma associated with salicylate intoxication. J Pediatr 1982; 100:493-496.
114. Erganian JA, Forbes GB, Case DM. Salicylate intoxication in the infant and young child, a report of thirteen cases. J Pediatr 1947; 30:129-145.
115. Everson GW, Krenzelok EP. Chronic salicylism in a patient with juvenile rheumatoid arthritis. Clin Pharm 1986; 5:334-341.
116. Fiscina S. Death associated with aspirin overdose. Mil Med 1986; 151:499.
117. Friedman SB, Stocks JF. Observations on the treatment of salicylism in children. N Engl J Med 1961; 265:1237-1241.
118. Griffith RA, Decker WJ, Wright CM. Iatrogenic salicylate poisoning of an infant by adult rectal aspirin suppositories. J Fam Pract 1981; 12:757-758.
119. Khan MI, Miller MT, Bartlett M. Complete recovery after profound acidosis (pH 6.49). Arch Dis Child 1984; 59:573-574.
120. Krasnoff SO, Bernstein M. Acetylsalicylic acid poisoning: with a report of a fatal case. J Am Med Assoc 1947; 135:712-714.
121. Mitchell I. "Therapeutic" salicylate poisoning in children. Br Med J 1979; 1:1081.
122. Schwartz JE. Chronic aspirin intoxication: a case report and literature review. Ariz Med 1984; 41:799-802.
123. Snodgrass W, Rumack BH, Peterson RG, Holbrook ML. Salicylate toxicity following therapeutic doses in young children. Clin Toxicol 1981; 18:247-259.
124. Temple AR, George DJ, Done AK, Thompson JA. Salicylate poisoning complicated by fluid retention. Clin Toxicol 1976; 9:61-68.
125. Whitehall J. Fatal salicylate poisoning: report on three fatal cases. Cent Afr J Med 1973; 19:25-27.
126. Dubow E, Solomon NH. Salicylate tolerance and toxicity in children. Pediatrics 1948; 1:495-503.
127. Lewis TV, Schaeffer SE, Hagemann TM, Badillo RB, McGoodwin PL. Misleading product packaging contributing to salicylate toxicity in an infant [abstract]. Clin Toxicol (Phila) 2005; 43:651.
128. Paynter AS, Alexander FW. Salicylate intoxication caused by teething ointment. Lancet 1979; 2:1132.
129. Hartmann AF. Acute salicylate poisoning. J Pediatr 1945; 26:214-215.
130. Coombs FS, Warren HA, Higley CS. Toxicity of salicylates. J Lab Clin Med 1945; 30:378-379.
131. Bressler R, Katz M, Conrad K. Woman with salicylate intoxication. Hosp Ther 1986; 11:117-118, 121.
132. Davis PR, Burch RE. Pulmonary edema and salicylate intoxication. Ann Intern Med 1974; 80:553-554.
133. Dellinger TM, Livingston HM. Aspirin burn of the oral cavity. Ann Pharmacother 1998; 32:1107.
134. Greer 3rd HD, Ward HP, Corbin KB. Chronic salicylate intoxication in adults. JAMA 1965; 193:555-558.
135. Good AE, Welch MH. Hospital-acquired salicylate intoxication. report of a case with psychosis, acidosis, and coma. J Rheumatol 1975; 2:52-60.
136. Granville-Grossman KL, Sergeant HG. Pulmonary oedema due to salicylate intoxication. Lancet 1960; 1:575-577.
137. Greenstein SM. Pulmonary edema due to salicylate intoxication: report of a case. Dis Chest 1963; 44:552-553.
138. Halla JT, Fallahi S, Hardin JG. Acute and chronic salicylate intoxication in a patient with gastric outlet obstruction. Arthritis Rheum 1981; 24:1205-1207.
139. Hazouard E, Grimbert M, Jonville-Berra AP, De Toffol MC, Legras A. Salicylisme et glaucome: augmentation réciproque de la toxicité de l'acétazolamine et de l'acid acétyl salicylique. J Fr Ophtalmol 1999; 22:73-75.
140. Kennedy J, Telford J. Altered mental status in salicylate poisoning: reversal with IV glucose [abstract]. J Toxicol Clin Toxicol 1998; 36:445.
141. Leatherman JW, Schmitz PG. Fever, hyperdynamic shock, and multiple-system organ failure. A pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest 1991; 100:1391-1396.
142. McVittie LAJ, Vicas IMO. A case of neonatal salicylism from maternal salicylate ingestion [abstract]. J Toxicol Clin Toxicol 1996; 34:570-571.
143. Palatnick W, Tenenbein M. Aspirin poisoning during pregnancy: increased fetal sensitivity. Am J Perinatol 1998; 15:39-41.
144. Paul BN. Salicylate poisoning in the elderly: diagnostic pitfalls. J Am Geriatr Soc 1972; 20:387-390.
145. Pei YP, Thompson DA. Severe salicylate intoxication mimicking septic shock. Am J Med 1987; 82:381-382.
146. Shkrum MJ, Gay RM, Hudson P. Fatal iatrogenic salicylate intoxication in a long-term user of enteric-coated aspirin. Arch Pathol Lab Med 1989; 113:89-90.
147. Steele TE, Morton Jr WA. Salicylate-induced delirium. Psychosomatics 1986; 27:455-456.
148. Sutcliffe J. Pulmonary oedema due to salicylates, with report of a case. Br J Radiol. 1955; 28:314-316.
149. Wise CM, Owen Jr DS, Jessee Jr EF. Another case of salicylate intoxication with enteric coated aspirin: association with gastric outlet obstruction. J Rheumatol 1982; 9:482-483.
150. Wrathall G, Sinclair R, Moore A, Pogson D. Three case reports of the use of haemodiafiltration in the treatment of salicylate overdose. Hum Exp Toxicol 2001; 20:491-495.
151. Estes D, Kaplan K. Lack of platelet effect with the aspirin analog, salsalate. Arthritis Rheum 1980; 23:1303.
152. Myers EN, Bernstein JM, Fostiropolous G. Salicylate ototoxicity: a clinical study. N Engl J Med 1965; 273:587-590.
153. Vernace MA, Bellucci AG, Wilkes BM. Chronic salicylate toxicity due to consumption of over-the-counter bismuth subsalicylate. Am J Med 1994; 97:308-309.
154. DuPont HL, Ericsson CD, Johnson PC, Bitsura JA, De la Cabada FJ. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987; 257:1347-1350.
155. Cohen A, Thomas GB, Cohen EB. Serum concentration, safety and tolerance of oral doses of choline magnesium trisalicylate. Curr Ther Res Clin Exp 1978; 23:358-367.
156. Hanzlik PJ, Presho NE. Liberation of salicyl from and excretion of methyl salicylate with a note on the irregular toxicity of the ester in man. J Pharmacol Exp Therap 1925; 26:71-81.
157. Chalasani N, Roman J, Jurado RL. Systemic inflammatory response syndrome caused by chronic salicylate intoxication. South Med J 1996; 89:479-482.
158. Graham JDP, Parker WA. The toxic manifestations of sodium salicylate therapy. Q J Med 1948; 17:153-163.
159. Ryder HW, Shaver M, Ferris EBJ. Salicylism accompanied by respiratory alkalosis and toxic encephalopathy. N Engl J Med 1945; 232:617-621.
160. Owen GC, Bradford HA. The prothrombinopenic effect of massive salicylate therapy in acute rheumatic fever. Ann Intern Med 1946; 25:97-102.
161. Vladutiu AO, Reitz M. Creatine kinase isoenzymes in aspirin intoxication. Lancet 1980; 2:864.
162. Andersen R, Refstad S. Adult respiratory distress syndrome precipitated by massive salicylate poisoning. Intensive Care Med 1978; 4:211-213.
163. Heng MC. Local necrosis and interstitial nephritis due to topical methyl salicylate and menthol. Cutis 1987; 39:442-444.
164. Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother 1996; 30:935-940.
165. Brubacher JR, Hoffman RS. Salicylism from topical salicylates: review of the literature. J Toxicol Clin Toxicol 1996; 34:431-436.
166. Cawley EP, Wheeler CE. Salicylic acid poisoning in dermatological therapy. J Am Med Assoc 1953; 151:372-374.
167. Cull M, Vicas IM-O. Salicylate toxicity with topical exposure on intact skin [abstract]. Clin Toxicol 2005; 43:640.
168. Davies MG, Briffa DV, Greaves MW. Systemic toxicity from topically applied salicylic acid. Br Med J 1979; 1:661.
169. Dwyer CM, McCloskey RH, Kerr RE. Poisoning from topical salicylic acid. Postgrad Med J 1994; 70:146.
170. Germann R, Schindera I, Kuch M, Seitz U, Altmeyer S, Schindera F. Lebensbedrohliche salicylat-intoxikation durch perkutane resorption bei einer schweren ichthyosis vulgaris. Hautarzt 1996; 47:624-627.
171. Leslie-Roberts H. On the absorption of salicylic acid by the human skin. Br J Dermatol Syph 1928; 40:328-344.
172. Luderschmidt C, Plewig G. Die chronisch perkutane salizylsä ureintoxikation. Hautarzt 1975; 26:643-646.
173. Pec J, Strmenova M, Palencarova E, Pullmann R, Funiakova S, Visnovsky P, Buchanec J, Lazarova Z. Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis. Cutis 1992; 50:307-309.
174. Peyriere H, Balmes N, Rouanet I, Mauboussin JM, Hillaire-Buys D, Arich C, Blayac JP, Vincent D. Acute salicylate intoxication after percutaneous absorption in an HIV patient treated for psoriasis. AIDS 2002; 16:1843-1844.
175. Shupp DL, Schroeter AL. An unusual case of salicylate toxicity. J Am Acad Dermatol 1986; 15:300-301.
176. Treguer H, Le Bihan G, Coloignier M, Le Roux P, Bernard JP. Intoxication salicylée par application locale de vaseline salicylée à 20% chez un psoriasique. Nouv Presse Med 1980; 9:192-193.
177. Von Weiss JF, Lever WF. Percutaneous salicylic acid intoxication in psoriasis. Arch Dermatol 1964; 90:614-619.
178. Young CJ. Salicylate intoxication from cutaneous absorption of salicylic acid. South Med J 1952; 45:1075-1077.
179. Abdel-Magid EH, el-Awad Ahmed FR. Salicylate intoxication in an infant with ichthyosis transmitted through skin ointment - a case report. Pediatrics 1994; 94:939-940.
180. Weigert SR, Gorisch V, Kluge C. Perkutane salizylss̈urevergiftung im säuglingsalter. Z Arztl Fortbild (Jena) 1978; 72:427-432.
181. Yamamura S, Kinoshita Y, Kitamura N, Kawai S, Kobayashi Y. Neonatal salicylate poisoning during the treatment of a collodion baby. Clin Pediatr (Phila) 2002; 41:451-452.
182. Bell AJ, Duggin G. Acute methyl salicylate toxicity complicating herbal skin treatment for psoriasis. Emerg Med (Freemantle) 2002; 14:188-190.
183. Etteldorf JN, Dobbins WT, Summitt RL, Rainwater WT, Fischer RL. Intermittent peritoneal dialysis using 5 percent albumin in the treatment of salicylate intoxication in children. J Pediatr 1961; 58:226-236.
184. Done AK. Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion. Pediatrics 1960; 26:800-807.
185. Winter JH. Hemoptysis and aspirin ingestion? Lancet 1983; 1:1441.
186. Botma M, Colquhoun-Flannery W, Leighton S. Laryngeal oedema caused by accidental ingestion of Oil of Wintergreen. Int J Pediatr Otorhinolaryngol 2001; 58:229-232.
187. Spontak SF, Hassan FM, Spadafora MP. Salsalate intoxication and ramifications of utilizing nonspecific analytical methods in estimating quantitative blood concentrations. J Anal Toxicol 1994; 18:229-231.
188. Garrettson LK, Procknal JA, Levy G. Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy. Clin Pharmacol Ther 1975; 17:98-103.
189. Greenberg MI, Hendrickson RG, Hofman M. Deleterious effects of endotracheal intubation in salicylate poisoning (letter). Ann Emerg Med 2003; 41:583-584.
190. Chyka PA, Seger D, Krenzelok EP, Vale JA. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: Single-dose activated charcoal. Clin Toxicol (Phila). 2005; 43:61-87.
191. Krenzelok EP, McGuigan M, Lheur P. Position statement: ipecac syrup. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997; 35:699-709.
192. Manoguerra AS, Cobaugh DJ. Guidelines for the Management of Poisoning Consensus Panel. Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons. Clin Toxicol (Phila) 2005; 43:1-10.
193. Barone JA, Raia JJ, Huang YC. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model. Ann Emerg Med 1988; 17:34-37.
194. Comstock EG, Boisaubin EV, Comstock BS, Faulkner TP. Assessment of the efficacy of activated charcoal following gastric lavage in acute drug emergencies. J Toxicol Clin Toxicol 1982; 19:149-165.
195. Curtis RA, Barone J, Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Arch Intern Med 1984; 144:48-52.
196. Danel V, Henry JA, Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. Br Med J (Clin Res Ed) 1988; 296:1507.
197. Dillon Jr EC. Wilton JH, Barlow JC, Watson WA. Large surface area activated charcoal and the inhibition of aspirin absorption. Ann Emerg Med 1989; 18:547-552.
198. Easom JM, Caraccio TR, Lovejoy Jr FH. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans. Clin Pharm 1982; 1:154-156.
199. Juhl RP. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption. Am J Hosp Pharm 1979; 36:1097-1098.
200. Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med 1990; 19:654-656.
201. Kirshenbaum LA, Mathews SC, Sitar DS, Tenenbein M. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther 1989; 46:264-271.
202. Mayersohn M, Perrier D, Picchioni AL. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose. Clin Toxicol 1977; 11:561-567.
203. Olkkola KT, Neuvonen PJ. Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol 1984; 18:663-669.
204. Rosenberg PJ, Livingstone DJ, McLellan BA. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal. Ann Emerg Med 1988; 17:681-683.
205. Sketris IS, Mowry JB, Czajka PA, Anderson WH, Stafford DT. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal. J Clin Pharmacol 1982; 22:59-64.
206. Levy G, Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Part I. Clin Pharmacol Ther 1972; 13:317-322.
207. Boxer L, Anderson FP, Rowe DS. Comparison of ipecac-induced emesis with gastric lavage in the treatment of acute salicylate ingestion. J Pediatr 1969; 74:800-803.
208. Prowse K, Pain M, Marston AD, Cumming G. The treatment of salicylate poisoning using mannitol and forced alkaline diuresis. Clin Sci 1970; 38:327-337.
209. Chapman BJ, Proudfoot AT. Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations. Q J Med 1989; 72:699-707.
210. Godfrey EE. Sodium bicarbonate therapy for salicylate poisoning. J Am Osteopath Assoc 1969; 69:346-355.
211. USP DI. Drug information for the Health Professional. Greenwood Village (CO): Thompson Micromedex, 2004. p. 2523-2524.
212. McEvoy GK, ed. AHFS Drug Information 2004. Bethesda: American Society of Health-System Pharmacists, 2004:1956.
213. Chan TY. The risk of severe salicylate poisoning following the ingestion of topical medicaments or aspirin. Postgrad Med J 1996; 72:109-112.